Inventor

VIRGIL SCOTT C

US16 patents

⚠️ This page may combine multiple inventors who share the name “VIRGIL SCOTT C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CALIFORNIA INST OF TECHN

10 patents

US10343996B2Jul 9, 2019

Quaternary heteroatom containing compounds

CALIFORNIA INST OF TECHN6 citations82

US10035769B2Jul 31, 2018

Quaternary heteroatom containing compounds

CALIFORNIA INST OF TECHN9 citations82

US10745354B2Aug 18, 2020

Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols

CALIFORNIA INST OF TECHN5 citations79

US10906875B2Feb 2, 2021

Synthetic transtaganolide and basiliolide products, derivatives thereof, and synthesis methods thereof

CALIFORNIA INST OF TECHN0 citations47

US8912347B2Dec 16, 2014

Synthetic transtaganolide and basiliolide products, derivatives thereof, and synthesis methods thereof

CALIFORNIA INST OF TECHN1 citations47

US10781213B2Sep 22, 2020

Methods for preparing bis-tetrahydroisoquinoline-containing compounds

CALIFORNIA INST OF TECHN0 citations42

STOLTZ BRIAN M

3 patents

US8822679B2Sep 2, 2014

Quaternary heteroatom containing compounds

STOLTZ BRIAN M14 citations81

US10358422B2Jul 23, 2019

Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols

STOLTZ BRIAN M6 citations77

US8653307B2Feb 18, 2014

Liphagal enantiomers and their derivatives and precursors, and enantioselective methods of making the same

STOLTZ BRIAN M0 citations41

AGOURON PHARMA

2 patents

US6953858B2Oct 11, 2005

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

AGOURON PHARMA4 citations57

US7179918B2Feb 20, 2007

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

AGOURON PHARMA0 citations47

MARX VANESSA M

1 patent

US9249170B2Feb 2, 2016

Cyclic alkyl amino carbene (CAAC) ruthenium complexes as improved catalysts for ethenolysis reactions

MARX VANESSA M9 citations75

VIRGIL SCOTT C

CALIFORNIA INST OF TECHN

Quaternary heteroatom containing compounds

Quaternary heteroatom containing compounds

Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols

Quaternary heteroatom containing compounds

Quaternary heteroatom containing compounds

Methods for preparing bis-tetrahydroisoquinoline-containing compounds

CDK inhibitors and uses thereof

Synthetic transtaganolide and basiliolide products, derivatives thereof, and synthesis methods thereof

Synthetic transtaganolide and basiliolide products, derivatives thereof, and synthesis methods thereof

Methods for preparing bis-tetrahydroisoquinoline-containing compounds

STOLTZ BRIAN M

Quaternary heteroatom containing compounds

Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols

Liphagal enantiomers and their derivatives and precursors, and enantioselective methods of making the same

AGOURON PHARMA

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

MARX VANESSA M

Cyclic alkyl amino carbene (CAAC) ruthenium complexes as improved catalysts for ethenolysis reactions